Training program to improve cancer research and treatment
Official title: T32 Training Program in Cancer Biology
Funded at Emory University · NIH-10874658 · Data updated 2026-11-12
This program is designed to help postdoctoral researchers in cancer biology learn from top experts at the Winship Cancer Institute, so they can connect lab research with real patient care and ultimately improve cancer treatments.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $355,227 |
| NIH project number | 5T32CA275777-02 |
| Project ID | NIH-10874658 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this program are postdoctoral researchers interested in cancer biology and its clinical applications.
✕Less likely to help
Patients who are not involved in research or do not have a background in cancer biology may not directly benefit from this program.
What this research studies
This program focuses on enhancing the training of postdoctoral researchers in cancer biology by bridging the gap between basic scientific research and clinical practice. It aims to provide a comprehensive mentorship experience at the Winship Cancer Institute, where trainees will learn from leading cancer biologists and clinicians. The program emphasizes the importance of rigorous scientific investigation alongside compassionate patient care, equipping trainees with the skills necessary to tackle significant biological questions and improve cancer treatment outcomes.
Why it matters
Potential benefit: If successful, this research could lead to transformative discoveries that enhance the quality of care for patients with cancer.
How similar studies have gone: Previous training programs in cancer biology have shown success in fostering collaboration between basic scientists and clinicians, leading to improved patient outcomes.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Yu, David Sung-Wen — Emory University
- Study coordinator: Yu, David Sung-Wen
Related research
Other NIH-funded projects on the same topics.
-
Administrative and Engagement Core for Breast Cancer Breakthrough in Kenya
A national effort in Kenya to speed up how we screen for breast cancer and connect women to treatment, using teamwork across institutions.
-
Collaborative research program to advance patient care
A multi-project research effort at Emory University aims to push forward medical knowledge that could help people with illnesses in the future.
-
Project-003: A multi-partner research program at Emory University
A multi-faceted NIH grant at Emory University aims to advance understanding in a focused area over several years to benefit patients with diseases or conditions connected to the research.
-
Project-002: advancing patient care through coordinated research at Emory
A multi-project NIH grant at Emory aims to translate findings into better care for people with a health condition by coordinating research efforts across teams.
-
Project-006: A Multidisciplinary Emory Initiative to Advance Medical Understanding
A multi-project NIH grant at Emory University aims to push forward medical knowledge in areas that could eventually help patients.
-
Project-005: A multi-component research effort at Emory University
A multi-part NIH grant from Emory University aims to advance understanding in a specific health area over several years with potential patient benefits in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.